Elliot

Corporate Finance

Headed for Redemption? GSK and its Strategic Turnaround

Download PDF Introduction Facing rising scrutiny from American activist investors, GlaxoSmithKline (GSK), Britain’s second-largest pharmaceutical company, is undertaking a major strategic shift. By spinning off its consumer healthcare division, and recently acquiring Sierra Oncology for $1.9bn, which is about to introduce a new blood cancer treatment to the market, GSK Read more…

By BSIC, 1 year ago

Corporate Finance

When a sweet deal doesn’t sound sweet enough: Temenos to acquire Fidessa for £1.4bn in cash

Temenos Group (SWX:TEMN) – market cap as of 23/02/2018: CHF7.60bn Fidessa Group (LON:FDSA) – market cap as of 23/02/2018: GBP1.47bn Introduction On February 21st, 2018, the boards of both Temenos and Fidessa have reached an agreement for the takeover of the former over the latter for £1.4 billion. The two Read more…

By BSIC, 5 years5 years ago

Corporate Finance

Headed for Redemption? GSK and its Strategic Turnaround

Corporate Finance

When a sweet deal doesn’t sound sweet enough: Temenos to acquire Fidessa for £1.4bn in cash

bsic_official